Kidney-Cancer Intersections: Complications, Checkpoints and Abnormalities - Charting a Course

7 Feb 2025 9:45 a.m. 11:15 a.m.
Amaltas Hall B101-A
GeorgiAbraham Chair IndiaMGM Healthcare, Chennai, India
KriangTungsanga Chair ThailandDepartment of Medicine, Faculty of Medicine, Chulalongkorn Unviersity
SanjayD'Cruz Chair IndiaGovernment Medical College & Hospital, Chandigarh

Session Description: 
This session explores the intricate interactions between novel cancer therapies and kidney function. Participants will gain a deeper understanding of the renal and electrolyte complications arising from new and emerging cancer treatments, including targeted therapies and immunotherapies. By analyzing real-world case studies and evidence-based practices, clinicians will be better equipped to recognize, manage, and mitigate these complications effectively. This session will also offer a comprehensive guide for establishing and operating an onconephrology clinic, as well as best practices for interdisciplinary collaboration. 
Learning Objectives:
1. Identify the mechanisms by which novel cancer therapies can lead to renal complications, including AKI and electrolyte abnormalities, and review the common clinical presentations and diagnostic approaches.
2. Distinguish immune-related kidney injury from other etiologies of AKI in cancer patients and formulate an evidence-based approach for managing ICI-associated renal toxicity.
3. Outline the key considerations and steps for setting up an onconephrology clinic. Recognize the importance of interdisciplinary collaboration in managing onconephrology patients.

Time Session
9:45 a.m.
10:03 a.m.
Renal Complications of Novel Cancer Therapies: Practical Insights
IK01-01
AnushreeShirali Speaker United StatesYale University
10:03 a.m.
10:21 a.m.
Immune Checkpoint Inhibitors and AKI
IK01-02
MitchellRosner Speaker United StatesUniveristy of Virginia Health
10:21 a.m.
10:39 a.m.
Electrolyte Abnormalities in the Cancer Patient
IK01-03
JolantaMalyszko Speaker PolandMedical University of Warsaw, Poland
10:39 a.m.
10:57 a.m.
Opening an Onconephrology Clinic - What Should You Be Aware of?
IK01-04
KenarJhaveri Speaker United StatesNorthwell Health
10:57 a.m.
11:15 a.m.
Q&A
IK01-05